Literature DB >> 28846187

Increased fear learning, spatial learning as well as neophobia in Rgs2-/- mice.

A Raab1,2,3, S Popp4, K-P Lesch2,4,5,6, M J Lohse2,7, M Fischer8, J Deckert2,8, L Hommers1,2,8.   

Abstract

Anxiety disorders result from a complex interplay of genetic and environmental factors such as stress. On the level of cellular signaling, regulator of G protein signaling 2 (Rgs2) has been implicated in human and rodent anxiety. However, there is limited knowledge about the role of Rgs2 in fear learning and reactivity to stress. In this study, Rgs2-/- mice showed increased fear learning, male mice displayed increased contextual and cued fear learning, while females showed selectively enhanced cued fear learning. Male Rgs2-/- mice displayed increased long-term-contextual fear memory, but increased cued fear extinction. Learning in spatial non-aversive paradigms was also increased in Rgs2-/- mice. Female, but not male mice show increased spatial learning in the Barnes maze, while male mice showed enhanced place preference in the IntelliCage, rendering enhanced cognitive function non-specific for aversive stimuli. Consistent with the previous results, Rgs2 deletion resulted in increased innate anxiety, including neophobic behavior expressed as hypolocomotion, in three different tests based on the approach-avoidance conflict. Acute electric foot shock stress provoked hypolocomotion in several exploration-based tests, suggesting fear generalization in both genotypes. Rgs2 deletion was associated with reduced monoaminergic neurotransmitter levels in the hippocampus and prefrontal cortex and disturbed corresponding GPCR expression of the adrenergic, serotonergic, dopaminergic and neuropeptide Y system. Taken together, Rgs2 deletion promotes improved cognitive function as well as increased anxiety-like behavior, but has no effect on acute stress reactivity. These effects may be related to the observed disruption of the monoaminergic systems.
© 2017 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  Anxiety; GPCR; Rgs2; cognition; conditioning; fear; fear conditioning; innate; learning; mice; mouse; neophobia; neurotransmitter; spatial

Mesh:

Substances:

Year:  2017        PMID: 28846187     DOI: 10.1111/gbb.12420

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  5 in total

1.  Serotonin Deficiency Increases Context-Dependent Fear Learning Through Modulation of Hippocampal Activity.

Authors:  Jonas Waider; Sandy Popp; Boris Mlinar; Alberto Montalbano; Francesco Bonfiglio; Benjamin Aboagye; Elisabeth Thuy; Raphael Kern; Christopher Thiel; Naozumi Araragi; Evgeniy Svirin; Angelika G Schmitt-Böhrer; Renato Corradetti; Christopher A Lowry; Klaus-Peter Lesch
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

Review 2.  Animal models of PTSD: a challenge to be met.

Authors:  Gal Richter-Levin; Oliver Stork; Mathias V Schmidt
Journal:  Mol Psychiatry       Date:  2018-10-19       Impact factor: 15.992

3.  RGS2 drives male aggression in mice via the serotonergic system.

Authors:  Melanie D Mark; Patric Wollenweber; Annika Gesk; Katja Kösters; Katharina Batzke; Claudia Janoschka; Takashi Maejima; Jing Han; Evan S Deneris; Stefan Herlitze
Journal:  Commun Biol       Date:  2019-10-11

Review 4.  Assessment of spatial learning and memory in the Barnes maze task in rodents-methodological consideration.

Authors:  Kinga Gawel; Ewa Gibula; Marta Marszalek-Grabska; Joanna Filarowska; Jolanta H Kotlinska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-23       Impact factor: 3.000

5.  Biomarker discovery in attention deficit hyperactivity disorder: RNA sequencing of whole blood in discordant twin and case-controlled cohorts.

Authors:  Timothy A McCaffrey; Georges St Laurent; Dmitry Shtokalo; Denis Antonets; Yuri Vyatkin; Daniel Jones; Eleanor Battison; Joel T Nigg
Journal:  BMC Med Genomics       Date:  2020-10-28       Impact factor: 3.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.